The White Aisle Foundation was established to honor the life of Rebecca Garrison-Sokoloff, founder and owner of The White Aisle, who died of melanoma on November 13, 2011. The foundation raises funds for melanoma research and patient support, as well as for other charities that Rebecca supported during her life.
September is Coming!!
Tickets are now available for our two annual fall fundraisers. :
Rebecca's Boston Birthday Celebration
Thursday, September 24, 2015
100 Warrenton St.
Complimentary hors d'oeuvres
Silent auction and raffle
Join us at Venu, one of the hottest new clubs in Rebecca's favorite city, to celebrate her birthday with an evening of food, drinks, and fun.
Fall Harvest Fest
Sunday, September 27, 2015
Silent auction and hors d'oeuvre reception begin at noon
Sit-down meal at 1 p.m
Gather with friends around the table at Acacia to share Chef Chris Voigtsberger's delicious and innovative dishes created from the bounty of local farms. Enjoy a luscious family-style harvest meal together with craft beer and wine, as you support melanoma research.
A huge thanks to everyone who supported this year's Move against Melanoma campaign. We have raised more than $9,000 so far this spring for melanoma research.
Our donations at work
The White Aisle Foundation is mentioned prominently in the most recent issue of the Beth Israel Deaconess Medical Center publication Giving Matters. An interview with Dr. David McDermott, whose work we support, quotes him as saying:
The White Aisle Foundation was created by the family of a young woman who was treated for metastatic melanoma with a drug that resulted in a dramatic, but unfortunately short-lived response. When this drug failed, she was too sick to receive the newer forms of immune therapy. The grant given in her memory was enough to collect and publish data and develop a clinical trial to compare her treatment with immune therapy. The research that was spurred by her unfortunate outcome and supported by her family and friends will help change the treatment for patients like her around the world.
We have contributed more than $50,000 thus far to Dr. McDermott's work, and continue our support through the Rebecca Garrison-Sokoloff Melanoma Research Endowment. Thank you for helping us make that happen.
Read the complete interview with Dr. McDermott on page 7 of the Fall/Winter 2014/2015 edition of Giving Matters.
In the news...
Promising results from combination therapy
A new 945-patient study shows that a combination of Yervoy (Ipiluminab) and the PD-1 inhibitor Opdivo (Nivolumab) is more effective in treating advanced melanoma than either therapy alone.
Discussing the study results at this year's ASCO meeting, Dr. Michael Atkins, formerly of Beth Israel Deaconess Medical Center and now at the Georgetown Lombardi Cancer Center, described this as another “breakthrough” in melanoma therapy. Given these results and results of an earlier study comparing pembrolizumab and ipilimumab, he said, nivolumab monotherapy and in combination with ipilimumab—along with pembrolizumab—should be considered new standards of care for advanced melanoma.
58% of patients in the study who received the combination saw their tumors shrink, compared with 44% on Opdivo alone and 19% on Yervoy. The average time of progression-free survival was 11.5 months for the combination, compared with 6.9 months for Opdivo alone and 2.9 months for Yervoy.
The combination therapy also resulted in a higher incidence of adverse side effects, however. This and the high cost of these drugs are among the issues that need to be addressed as research moves forward.
Call to Action to Prevent Skin Cancer
In July, the U.S. Department of Health and Human Services released the Surgeon General's Call to Action to Prevent Skin Cancer. This remarkable document marks the first time the Surgeon General's office has declared openly that UV radiation is harmful and that people need to protect themselves from its effects. It also lays out an action plan to stem the "rising tide of skin cancer" that has seen the incidence of melanoma alone triple over the last 35 years. The White Aisle Foundation looks forward to participating in this historic national effort to educate and change attitudes about sun safety.
Support us by...
The Rebecca Garrison Sokoloff Melanoma Research Endowment
In 2013, the foundation began a five-year campaign to raise $100,000 for the Rebecca Garrison Sokoloff Melanoma Research Endowment at Beth Israel Deaconess Medical Center. The endowment will advance melanoma research and training by directly funding young researchers. It will:
With our second $20,000 pledge payment at the end of 2014, we are almost halfway toward that goal.
Help us get the rest of the way!!